North China Pharmaceutical Co Ltd (600812) — Free Cash Flow Generation Index
North China Pharmaceutical Co Ltd (600812) has a Free Cash Flow Generation Index of 0.15x as of September 2025. Free cash flow of CN¥25.86 Million represents 0% of operating cash flow (CN¥170.24 Million). See North China Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
North China Pharmaceutical Co Ltd Free Cash Flow Generation Index (2000–2025)
Historical FCF Generation Index trend for North China Pharmaceutical Co Ltd across 22 annual periods. Explore North China Pharmaceutical Co Ltd (600812) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for North China Pharmaceutical Co Ltd (2000–2025)
Year-by-year Free Cash Flow Generation Index for North China Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600812 stock market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥634.53 Million | CN¥1.18 Billion | CN¥542.01 Million | ▲ +48.9% |
| 2024 | 0.36x | CN¥445.35 Million | CN¥1.23 Billion | CN¥784.22 Million | ▼ -7.5% |
| 2023 | 0.39x | CN¥401.23 Million | CN¥1.02 Billion | CN¥623.04 Million | ▼ -13.5% |
| 2022 | 0.45x | CN¥454.81 Million | CN¥1.00 Billion | CN¥549.58 Million | ▼ -5.4% |
| 2021 | 0.48x | CN¥502.75 Million | CN¥1.05 Billion | CN¥547.50 Million | ▲ +241.4% |
| 2020 | -0.34x | CN¥-254.68 Million | CN¥752.15 Million | CN¥1.01 Billion | ▼ -385.3% |
| 2019 | 0.12x | CN¥87.00 Million | CN¥732.97 Million | CN¥645.97 Million | ▼ -65.7% |
| 2018 | 0.35x | CN¥267.69 Million | CN¥774.33 Million | CN¥506.64 Million | ▲ +188.3% |
| 2017 | -0.39x | CN¥-112.44 Million | CN¥287.25 Million | CN¥399.69 Million | ▲ +80.5% |
| 2015 | -2.00x | CN¥-245.32 Million | CN¥122.50 Million | CN¥367.81 Million | ▼ -8.1% |
| 2014 | -1.85x | CN¥-167.73 Million | CN¥90.56 Million | CN¥258.30 Million | ▲ +53.6% |
| 2011 | -3.99x | CN¥-909.21 Million | CN¥227.60 Million | CN¥1.14 Billion | ▼ -726.2% |
| 2009 | 0.64x | CN¥645.03 Million | CN¥1.01 Billion | CN¥366.10 Million | ▼ -26.9% |
| 2008 | 0.87x | CN¥947.52 Million | CN¥1.09 Billion | CN¥138.00 Million | ▲ +2.4% |
| 2007 | 0.85x | CN¥566.10 Million | CN¥664.37 Million | CN¥98.27 Million | ▼ -6.7% |
| 2006 | 0.91x | CN¥545.39 Million | CN¥597.12 Million | CN¥51.72 Million | ▲ +418.3% |
| 2005 | 0.18x | CN¥39.50 Million | CN¥224.17 Million | CN¥184.67 Million | ▲ +243.5% |
| 2004 | -0.12x | CN¥-38.11 Million | CN¥310.39 Million | CN¥348.50 Million | ▼ -151.8% |
| 2003 | 0.24x | CN¥137.54 Million | CN¥580.32 Million | CN¥442.77 Million | ▼ -65.9% |
| 2002 | 0.70x | CN¥513.82 Million | CN¥738.50 Million | CN¥224.68 Million | ▲ +45.6% |
| 2001 | 0.48x | CN¥175.49 Million | CN¥367.28 Million | CN¥191.79 Million | ▲ +77.3% |
| 2000 | 0.27x | CN¥35.97 Million | CN¥133.49 Million | CN¥97.52 Million | — |